Get the Stockscreener App
1.58
0.64%
0.01
After Hours:
1.52
-0.06
-3.80%
Rafael Holdings Inc stock is traded at $1.58, with a volume of 250.42K.
It is up +0.64% in the last 24 hours and up +16.18% over the past month.
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
See More
Previous Close:
$1.57
Open:
$1.55
24h Volume:
250.42K
Relative Volume:
1.28
Market Cap:
$100.04M
Revenue:
$697.00K
Net Income/Loss:
$-39.78M
P/E Ratio:
-0.9461
EPS:
-1.67
Net Cash Flow:
$-8.90M
1W Performance:
-23.67%
1M Performance:
+16.18%
6M Performance:
-18.97%
1Y Performance:
+8.22%
1-Day Range:
$1.54
$1.65
1-Week Range:
$1.41
$2.0707
52-Week Range:
$1.28
$3.19
Rafael Holdings Inc Stock (RFL) Company Profile
Name
Rafael Holdings Inc
Sector
Industry
Phone
212-658-1450
Address
520 BROAD STREET, NEWARK
Compare RFL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RFL
Rafael Holdings Inc
|
1.58 | 100.04M | 697.00K | -39.78M | -8.90M | -1.67 |
|
CBRE
Cbre Group Inc
|
133.89 | 39.60B | 36.74B | 1.01B | 1.35B | 3.27 |
|
CSGP
Costar Group Inc
|
79.65 | 34.20B | 2.81B | 117.20M | -30.60M | 0.29 |
|
BEKE
Ke Holdings Inc Adr
|
18.00 | 22.71B | 12.30B | 566.18M | 1.32B | 0.4805 |
|
JLL
Jones Lang Lasalle Inc
|
238.46 | 11.28B | 24.05B | 536.00M | 508.40M | 11.06 |
|
FSV
Firstservice Corp
|
172.74 | 8.17B | 4.93B | 108.16M | 203.45M | 2.40 |
Rafael Holdings Inc Stock (RFL) Latest News
Rafael to continue phase 3 study of NPC treatment after DMC review - Investing.com Nigeria
Rafael Holdings Advances Phase 3 Study for NPC1 Treatment - TipRanks
Major Breakthrough: Phase 3 Trial for Fatal Rare Disease NPC1 Gets Critical DMC Approval to Continue - Stock Titan
Rafael Holdings, Inc. (NYSE:RFL) Short Interest Update - MarketBeat
Howard S. Jonas Acquires 13,080,457 Shares of Rafael Holdings, Inc. (NYSE:RFL) Stock - MarketBeat
Rafael Holdings Up 29%, Insider Buyers Are Up 61% - Yahoo Finance
Retail investors invested in Rafael Holdings, Inc. (NYSE:RFL) up 29% last week, insiders too were rewarded - simplywall.st
Rafael Holdings Reports Improved Financial Results and Strategic Progress - TipRanks
Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2025 - MarketScreener
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
Rafael (NYSE:RFL) Posts Quarterly Earnings Results - MarketBeat
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results - The Manila Times
Rafael Holdings Slashes Losses 85% as Crucial Phase 3 Rare Disease Trial Results Loom - Stock Titan
Rafael Holdings stock surges after CEO acquires $16.7m in shares - Investing.com Nigeria
Rafael Holdings stock surges after CEO acquires $16.7m in shares By Investing.com - Investing.com South Africa
Rafael Holdings Completes $25M Rights Offering - TipRanks
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering - The Manila Times
RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics - The Manila Times
Rafael Holdings Announces Final Results And Closing Of Rights Offering - MarketScreener
Rafael CEO Backs $25M Rights Offering to Fund Critical Phase 3 Rare Disease Drug Trial - Stock Titan
Israel Defense Exports Hit Record in 2024 as Europe Demand Jumps - Bloomberg
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - The Manila Times
Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy? - Defense World
Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com India
Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan
RFL stock touches 52-week low at $1.28 amid market challenges - Investing.com Australia
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trap - The Manila Times
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - The Manila Times
Rafael Holdings Rights Offering: $25M Deal Terms Revealed, May 29 Deadline Approaches - Stock Titan
Ekso Bionics reports Q1 results, plans reverse stock split - The North Bay Business Journal
Ekso Bionics Accepted into NVIDIA Connect Program - Quantisnow
Dassault Aviation Shares Continue to Drop After the Rafale Jet Shot Down - TECHi
Rafael : to Present at LD Micro Investor Conference - marketscreener.com
Rafael Holdings Enters Standby Purchase Agreement with Chairman - TipRanks
SEC Form 424B3 filed by Rafael Holdings Inc. - Quantisnow
Ekso Bionics: Q1 Earnings Snapshot - CTPost
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - ADVFN
Rafael announces revised subscription rights in connection with offering - TipRanks
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
Press Release Distribution & PR Platform - ACCESS Newswire
LD Micro 360 Companies: --Set to Present this Week. - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings Inc Stock (RFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):